HLA-DRB1*03 and DQB1*0302 associations in a subset of patients severely affected with systemic lupus erythematosus from western India

Genetic factors are likely to be important both in determining the overall susceptibility to systemic lupus erythematosus (SLE) and in influencing the remarkable clinical heterogeneity in disease expression found in affected subjects. The more common clinical features seen in patients with SLE include, skin and joint diseases, renal disease, neuropsychiatric complications, and also some haematological abnormalities. Genetic factors, together with environmental factors, strongly influence the development of SLE. Multiple loci within the major histocompatibility complex (MHC) have been implicated in susceptibility as have HLA class II alleles, complement components, and tumour necrosis factor (TNF) loci. Currently it is believed that some HLA alleles are in genetic linkage disequilibrium with certain disease related genes and they regulate the immune responses. Since 1969, when the first case of SLE was reported from India, the disease has been extensively studied in different regions of the country—namely, Chennai, Calcutta, Mumbai, and New Delhi. A statistically significant clinical correlation comparing the clinical variables from other racial groups of the world has been reported in Indian patients with SLE.1 HLA association studies from Indian patients …

[1]  C. Carcassi,et al.  HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus , 2003, Lupus.

[2]  M. Kuo,et al.  HLA-DRB1 antigens in Taiwanese patients with juvenile-onset systemic lupus erythematosus , 2001, Rheumatology International.

[3]  K. Tokunaga,et al.  Analysis of the association of HLA-DRB1, TNFα promoter and TNFR2 (TNFRSF1B) polymorphisms with SLE using transmission disequilibrium test , 2001, Genes and Immunity.

[4]  D. Alarcón-Segovia,et al.  Class II allele and haplotype frequencies in Mexican systemic lupus erythematosus patients: the relevance of considering homologous chromosomes in determining susceptibility. , 2001, Human immunology.

[5]  M. Azizah,et al.  HLA Antigens in Malay Patients with Systemic Lupus Erythematosus: Association with Clinical and Autoantibody Expression , 2001, The Korean journal of internal medicine.

[6]  M. V. van Krugten,et al.  TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. , 2000, Arthritis and rheumatism.

[7]  D. Gladman,et al.  Disease expression and class II HLA antigens in systemic lupus erythematosus , 1999, Lupus.

[8]  R. Fossdal,et al.  A study of the association of HLA DR, DQ, and complement C4 alleles with systemic lupus erythematosus in Iceland , 1998, Annals of the rheumatic diseases.

[9]  J. Gómez-Reino,et al.  Differential contribution of HLA-DR, DQ, and TAP2 alleles to systemic lupus erythematosus susceptibility in Spanish patients: role of TAP2*01 alleles in Ro autoantibody production , 1998, Annals of the rheumatic diseases.

[10]  A. Malaviya,et al.  Occasional Series—Lupus Around the World Systemic lupus erythematosus in India , 1997 .

[11]  V. Taneja,et al.  Major Histocompatibility Complex Genes and Susceptibility to Systemic Lupus Erythematosus in Northern India , 1993, Lupus.